Key result
Extreme maximum P-wave durations (≥141 ms) predicted new-onset atrial fibrillation (HR 1.52; 95% CI 1.32-1.75; P<0.001) and mortality in heart failure patients compared to 101-120 ms.
Why the study?
P-wave indices derived from automated ECG measurements had not been explored for their predictive value regarding adverse outcomes in heart failure.
Do extreme values of maximum P-wave duration predict new-onset atrial fibrillation and mortality in patients with heart failure?
Cohort (n=2,718)
No
Do extreme values of maximum P-wave duration predict new-onset atrial fibrillation and mortality in patients with heart failure?
Hazard Ratio: 1.52 (95% CI 1.32–1.75)
p-value: p=< 0.001
Extreme values of maximum P-wave duration (≤90 ms and ≥141 ms) derived from automated ECG analysis are significant predictors of incident AF and mortality in heart failure patients.
Extreme automated P-wave durations were associated with AF and mortality in HF; extends indices to this population but leaves open prospective validation.
BACKGROUND: P-wave indices have been used to predict incident atrial fibrillation (AF), stroke, and mortality. However, such indices derived from automated ECG measurements have not been explored for their predictive values in heart failure (HF). We investigated whether automated P-wave indices can predict adverse outcomes in HF. METHODS: This study included consecutive Chinese patients admitted to a single tertiary centre, presenting with HF but without prior AF, and with at least one baseline ECG, between 1 January 2010 and 31 December 2016, with last follow-up of 31 December 2019. RESULTS: A total of 2718 patients were included [median age: 77.4, interquartile range (IQR): (66.9-84.3) years; 47.9 males]. After a median follow-up of 4.8 years (IQR: 1.9-9.0 years), 1150 patients developed AF (8.8/year), 339 developed stroke (2.6/year), 563 developed cardiovascular mortality (4.3/year), and 1972 had all-cause mortality (15.1/year). Compared with 101-120 ms as a reference, maximum P-wave durations predicted new-onset AF at ≤90 ms [HR: 1.17(1.11, 1.50), P < 0.01], 131-140 ms [HR: 1.29(1.09, 1.54), P < 0.001], and ≥141 ms [HR: 1.52(1.32, 1.75), P < 0.001]. Similarly, they predicted cardiovascular mortality at ≤90 ms [HR: 1.50(1.08, 2.06), P < 0.001] or ≥141 ms [HR: 1.18(1.15, 1.45), P < 0.001], and all-cause mortality at ≤90 ms [HR: 1.26(1.04, 1.51), P < 0.001], 131-140 ms [HR: 1.15(1.01, 1.32), P < 0.01], and ≥141 ms [HR: 1.31(1.18, 1.46), P < 0.001]. These remained significant after adjusting for significant demographics, past co-morbidities, P-wave dispersion, and maximum P-wave amplitude. CONCLUSIONS: Extreme values of maximum P-wave durations (≤90 ms and ≥141 ms) were significant predictors of new-onset AF, cardiovascular mortality, and all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2022) conducted a cohort in Heart failure (n=2,718). Maximum P-wave duration ≥141 ms vs. Maximum P-wave duration 101-120 ms was evaluated on New-onset atrial fibrillation (HR 1.52, 95% CI 1.32-1.75, p=< 0.001). Extreme maximum P-wave durations (≥141 ms) predicted new-onset atrial fibrillation (HR 1.52; 95% CI 1.32-1.75; P<0.001) and mortality in heart failure patients compared to 101-120 ms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: